Achilles Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Apr '25 Apr 30, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022
Net Income	0.6	-0.03	0	-0
Change in Accounts Payable	0.01	-0	0	0
Change in Unearned Revenue	0.72	-0.01	0.01	-
Change in Other Net Operating Assets	-0.23	-0	0	-
Operating Cash Flow	0.5	-0.05	0.02	-
Issuance of Common Stock	-	0.14	0	-
Financing Cash Flow	0.01	0.14	0	-
Net Cash Flow	0.51	0.09	0.02	-
Cash Income Tax Paid	-	-	0	-
Levered Free Cash Flow	0.4	-0.05	-	-
Unlevered Free Cash Flow	0.4	-0.05	-	-
Change in Working Capital	-0.1	-0.02	0.02	0

Source: S&P Global Market Intelligence. Standard template. Financial Sources.